Clinical Trial Update: Effect of Acetazolamide on Cognition in Patients With Respiratory Disease at Altitude [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of acetazolamide on cognition in COPD patients at altitude has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Status: COMPLETED